Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
ABOS

ABOS - Acumen Pharmaceuticals, Inc. Stock Price, Fair Value and News

$3.27-0.03 (-0.91%)
Market Closed

Price Targets

ABOS Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

ABOS Price Action

Last 7 days

-1.2%

Last 30 days

27.7%

Last 90 days

52.8%

Trailing 12 Months

168.0%

ABOS RSI Chart

ABOS Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

ABOS Valuation

Market Cap

198.1M

Price/Earnings (Trailing)

-1.49

Price/Sales (Trailing)

10.95

Price/Free Cashflow

-1.6

ABOS Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

ABOS Fundamentals

ABOS Revenue

Revenue (TTM)

10.8M

ABOS Earnings

Earnings (TTM)

-133.4M

Earnings Growth (Yr)

11.13%

Earnings Growth (Qtr)

35.41%

ABOS Profitability

Return on Equity

-143.12%

Return on Assets

-93.76%

Free Cashflow Yield

-62.43%

ABOS Investor Care

Shares Dilution (1Y)

0.82%

Diluted EPS (TTM)

-2.22

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20240000
20236.6M0010.8M
20220002.4M
20200001.4M
Get all data in R, Python etc through our Historical Stock Data APIs

About Acumen Pharmaceuticals, Inc.

ABOS
Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is headquartered in Charlottesville, Virginia.
 CEO
 WEBSITEhttps://acumenpharm.com
 SECTORHealthcare
 INDUSTRYBiotechnology
 EMPLOYEES39

Acumen Pharmaceuticals, Inc. Frequently Asked Questions

ABOS is the stock ticker symbol of Acumen Pharmaceuticals, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

As of Fri Mar 13 2026, market cap of Acumen Pharmaceuticals, Inc. is 198.08 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

As of Fri Mar 13 2026, ABOS's PE ratio (Price to Earnings) is -1.49 and Price to Sales (PS) ratio is 10.95. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. ABOS PE ratio will change depending on the future growth rate expectations of investors.